Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:911-917
Published online before print March 4, 2004, doi: 10.1161/01.ATV.zhq0504.7914
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/5/911    most recent
01.ATV.zhq0504.7914v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmitt, M.
Right arrow Articles by Frenneaux, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmitt, M.
Right arrow Articles by Frenneaux, M. P.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Congestive
Right arrow Cardiovascular Pharmacology
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:911.)
© 2004 American Heart Association, Inc.


Vascular Biology

Effects of Exogenous and Endogenous Natriuretic Peptides on Forearm Vascular Function in Chronic Heart Failure

Matthias Schmitt; Prasad Gunaruwan; Nicola Payne; Justin Taylor; Leong Lee; Andrew J.M. Broadley; Angus K. Nightingale; John R. Cockcroft; Allan D. Struthers; John V. Tyberg; Michael P. Frenneaux

From the Wales Heart Research Institute (M.S., P.G., J.T., L.L., A.J.M.B., A.K.N., J.R.C., M.P.F.), Cardiff, UK; the Medical Data Research Centre (N.P.), Providence Health System, Ore; the Department of Clinical Pharmacology (A.D.S.), Ninewells Hospital, Dundee, UK; and the Department of Medicine and Medical Physiology (J.V.T.), University of Calgary, Alberta, Canada.

Correspondence to Dr Matthias Schmitt, University of Wales, College of Medicine, Department of Cardiology, Wales Heart Research Institute, Heath Park, Cardiff, UK CF14 4XN. E-mail matthschmitt{at}doctors.org.uk

Objective— Natriuretic peptides (NPs) reduce central venous pressure in patients with chronic heart failure (cHF) despite attenuation of arterial, renal, and humoral effects. This suggests a preserved venodilator response. This study had 4 aims: to compare the venodilator effects of human NPs in patients with cHF; to assess the contribution of basal ANP and BNP levels to regulation of forearm vascular volume (FVV); to test the hypothesis that venous ANP responsiveness is preserved in cHF; and to assess the involvement of endothelial nitric oxide-synthase (eNOS) in NP-induced vascular effects.

Methods and Results— Venous and arterial forearm vascular responses to incremental intra-arterial doses of ANP, Urodilatin, BNP, CNP, or the ANP receptor antagonist A71915 were studied in 53 patients and 11 controls. ANP receptor antagonism reduced FVV by 4.4%±1.2% (P<0.05). The forearm blood flow (FBF) response to ANP was significantly blunted in patients versus controls (P<0.01), whereas FVV increased similarly in both groups (maximum 14.7% and 13.4%, both P<0.001). The eNOS blockade reduced ANP-induced FBF changes in controls but not in patients (P<0.05), whereas similar reductions in FVV changes were seen in groups (both P<0.001).

Conclusions— In cHF venous, but not arterial, ANP responsiveness is preserved. Arterial endothelial dysfunction may contribute to NP resistance.


Key Words: veins • capacitance • receptor antagonism • A71915




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
S. Balmain, N. Padmanabhan, W. R. Ferrell, J. J. Morton, and J. J.V. McMurray
Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function
Eur J Heart Fail, September 1, 2007; 9(9): 865 - 871.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Singh, R. E. Kuc, J. J. Maguire, M. Fidock, and A. P. Davenport
Novel Snake Venom Ligand Dendroaspis Natriuretic Peptide Is Selective for Natriuretic Peptide Receptor-A in Human Heart: Downregulation of Natriuretic Peptide Receptor-A in Heart Failure
Circ. Res., July 21, 2006; 99(2): 183 - 190.
[Abstract] [Full Text] [PDF]